Trending:
Lonza and GE Healthcare are developing a new biologics facility in Guangzhou, China.
Lonza and GE Healthcare are developing a new biologics facility in Guangzhou, China.
Read More...
In November 2018, GE Healthcare opened a new manufacturing centre in Stevenage, UK. The facility...
Read More...
Oregon Health & Science University’s (OHSU) Knight Cancer Institute built a new research building at...
Read More...
Seqirus, a biotherapeutics company based in Australia, announced plans to expand its flu vaccine manufacturing facility...
Read More...
Abzena is expanding its biotherapeutics manufacturing operations by relocating to a new leased facility in...
Read More...
Japanese pharmaceutical company Astellas Pharma has announced plans to relocate its wholly-owned US subsidiary Astellas...
Read More...
Medicago is constructing a new influenza vaccine production facility in the Estimauville Innovation Area in Quebec...
Read More...
Grand River Aseptic Manufacturing (GRAM) is constructing its third pharmaceutical manufacturing facility in Grand Rapids,...
Read More...
Germany-based pharmaceutical company Boehringer Ingelheim is constructing a new large-scale cell culture (LSCC) facility at...
Read More...
Lonza is developing a new biomanufacturing complex at its biopark in Visp, Switzerland.
Read More...
Go Top
